Pangaea is an influential global think tank, convening experts from around the world to improve HIV and Hepatitis C treatment guidelines, to help countries deliver HIV services more effectively, and to fight the stigma and discrimination still faced by people living with and affected by HIV. We design policies and support countries as they implement innovative approaches to providing HIV prevention, testing and treatment that are urgently needed by vulnerable and marginalized groups. We also work with leading multinational corporations with strong social responsibility commitments to implement and update comprehensive HIV education testing and treatment programs.
Through collaboration with our partners from around the world, our programs focus on: technical cooperation, research and social policy, and global policy and development.
We support national governments and local partners to design and deliver innovative programs that help people affected by HIV, breast and cervical cancer, and viral hepatitis lead healthy and productive lives.
- In China, advising provincial and city authorities to establish confidential HIV testing and linkage to care services for gay men, and now utilizing the lessons from HIV community mobilization to help women’s groups scale up breast cancer screening and treatment services.
- In Oakland, supporting local partners in implementing ground-breaking Pre-Exposure Prophylaxis (PrEP) services for young men of color who have sex with men.
- Supporting major international corporations develop workplace programs and policies for HIV, TB and Hepatitis B and C.
- Helping the Tanzanian Government provide clean needles, methadone and other harm reduction and HIV services to its increasing population of people who inject drugs.
- Supporting national adaptation of global HIV treatment guidelines in Zimbabwe
Research and Social Policy
We conduct implementation research to gather evidence about ‘what works’ in the local context to ensure equitable access to prevention, testing, treatment and care.
- Best Practices Program designed to develop and cost a series of case studies documenting ARV treatment and support programs that are improving the uptake and retention of clients in care and on treatment.
- Working in Chitungwiza, Zimbabwe with the SHAZ!-HUB to determine how to best meet the HIV and SRH needs of young and adolescent women, including the potential use of PrEP and microbicides for ARV-based HIV prevention.
- Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study.
- Inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania.
- In Zimbabwe, providing monitoring and evaluation support through participation in two major consortia in delivering clinical mentorship and community support for people living with HIV.
Global Policy and Diplomacy
Pangaea convenes experts from science, health services, affected communities and the private sector to consider the evidence and develop HIV/AIDS policies and programs to reach vulnerable and marginalized groups. In addition, Pangaea staff provide targeted advice to international health institutions as they develop new policies and guidelines that will shape programs around the world.
- Pangaea works to bring global researchers, health care providers, drug manufacturers, policy makers, funders, and community members together in order to develop optimal drugs, diagnostics and service delivery for all those affected by HIV, including organizing the CADO 2 and Vancouver Treatment Optimization Meeting.
- Adapting lessons from HIV for broader health priorities, such as applying lessons from HIV community mobilization and adapting them to help women’s groups scale up breast cancer screening and treatment services in China and Tanzania.
- Providing global leadership: facilitating the Global Fund’s 2015 Partnership Forums, participating in high level meetings and roundtables, and advocating for increased donor and multilateral action in the response to AIDS.